Melevodopa
Melevodopa, a notable dopaminergic agent, serves as the methyl ester variant of levodopa, a precursor to the neurotransmitters dopamine, norepinephrine, and epinephrine. Recognized for its enhanced water solubility, melevodopa is widely utilized in the medical domain as an effervescent prodrug in tablet form.
Chemical Properties[edit]
- Structural Formula: Being the methyl ester form of levodopa, melevodopa possesses a methoxy functional group replacing the carboxylic acid group in levodopa.
- Solubility: Melevodopa stands out for its remarkable water solubility, boasting a solubility that's 250 times higher than that of tablet levodopa. This heightened solubility is a definitive factor behind its usage in effervescent tablet forms.
Pharmacology[edit]
Melevodopa, functioning as a prodrug, undergoes metabolic conversion in the body to produce levodopa, which subsequently gets decarboxylated to produce the neurotransmitter, dopamine. This dopamine replacement strategy is a cornerstone in the treatment of conditions marked by dopamine deficiency, such as Parkinson's disease.
Medical Uses[edit]
Given its dopaminergic properties, melevodopa plays a pivotal role in the treatment of diseases characterized by dopamine deficits. Its ability to restore dopamine levels and counter the deleterious effects of dopamine insufficiency makes it an asset in the therapeutic domain.
Advantages over Levodopa[edit]
Melevodopa offers certain benefits when contrasted with traditional levodopa tablets:
- Enhanced Solubility: With a water solubility that eclipses levodopa by a factor of 250, melevodopa can be effortlessly formulated into effervescent tablet forms. This high solubility ensures rapid dissolution and absorption, promoting quicker therapeutic action.
- Potential Reduced Side Effects: As a prodrug, melevodopa may exhibit a more consistent and controlled release of dopamine once metabolized, potentially reducing the risk of side effects associated with sudden dopamine surges.
See Also[edit]
See also[edit]
| Antiparkinson agents (N04) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Phenethylamines | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
 | This drug article relating to the nervous system is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
